Related Experiment Video
Updated: Jun 24, 2026

09:21
Serum and Plasma Copy Number Detection Using Real-time PCR
Published on: December 15, 2017
A simple multiplex real-time PCR methodology for the SMN1 gene copy number quantification
Nadia Passon1, Federico Pozzo, Cristiano Molinis
1Dipartimento di Scienze e Tecnologie Biomediche, Università degli Studi, Udine, Italy.
Genetic Testing and Molecular Biomarkers
|March 25, 2009
Summary
This study presents a new multiplex real-time PCR method for accurate spinal muscular atrophy (SMA) diagnosis. The improved TaqMan assay enhances SMN1 gene copy number assessment for reliable carrier identification and diagnosis.
Area of Science:
- Genetics
- Molecular Biology
- Medical Diagnostics
Background:
- Spinal muscular atrophy (SMA) is a genetic disorder often caused by SMN1 gene deletion.
- Current diagnostic methods like PCR-RFLP have limitations, especially for carrier detection.
- TaqMan technology is widely used for SMN1 copy number evaluation but faces challenges with DNA extraction and quantification.
Purpose of the Study:
- To develop a reliable, reproducible, and user-friendly TaqMan-based protocol for SMN1 gene copy number assessment.
- To overcome limitations of existing simplex TaqMan assays for SMA diagnosis.
- To facilitate interlaboratory data exchange and reduce diagnostic costs.
Main Methods:
- Development of a multiplex real-time PCR assay combining target (SMN1) and reference gene amplification in a single reaction.
- Validation of the protocol for SMN1 gene copy number evaluation.
- Comparison with simplex TaqMan methodologies.
Main Results:
- The multiplex real-time PCR protocol provides a reliable and highly reproducible method for SMN1 gene copy number assessment.
- This approach minimizes issues related to DNA extraction methods and template quantification.
- The multiplex assay reduces the need for replicate tests, lowering overall diagnostic costs.
Conclusions:
- The developed multiplex real-time PCR protocol offers an improved diagnostic tool for SMA.
- It enhances accuracy and efficiency in SMN1 gene copy number determination.
- The protocol supports standardized interlaboratory results and cost-effective genetic testing for SMA.

